COMMUNIQUÉS West-GlobeNewswire

GENFIT : étape importante franchie avec la fin du recrutement des patients de l'essai de Phase 2 évaluant elafibranor dans la PBC
28/08/2018
GENFIT : étape importante franchie avec la fin du recrutement des patients de l'essai de Phase 2 évaluant elafibranor dans la PBC Randomisation du dernier patient de l'essai de phase 2a évaluant l'efficacité et l' [...]
GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology
28/08/2018
VIENNA, Austria, Aug. 28, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the development and commercialization of cannabinoid prescription medicines, [...]
ObsEva SA to Participate in September Investor Conferences
28/08/2018
Geneva, Switzerland and Boston, MA – August 28, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
MDxHealth (R): SelectMDx Cost-effective in Four European Countries
28/08/2018
NEWS RELEASE REGULATED INFORMATION Potential healthcare cost savings in France, Germany, Italy and Spain of over €300 million IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CEST, 28 August 2018 - MDxHealth SA (Euronext: MDXH. [...]
MDxHealth (R) :
28/08/2018
MDxHealth (R): SelectMDx Cost-effective in Four European Countries
28/08/2018
NEWS RELEASE REGULATED INFORMATION Cost savings for healthcare providers in France, Germany, Italy and Spain of over €300 million IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CEST, 28 August 2018 - MDxHealth SA (Euronext: [...]
MDxHealth (R) : SelectMDx : rapport coût-effectivité positif dans quatre pays européens
28/08/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES Une économie potentielle de plus de 300 millions d'euros sur les soins de santé en France, en Allemagne, en Italie et en Espagne IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 [...]
Biocartis Group NV: Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response to Targeted Colorectal Cancer Therapy
28/08/2018
PRESS RELEASE : 28 August 2018, 07:00 CEST Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response to Targeted Colorectal Cancer Therapy Mechelen, Belgium, 28 August 2018 [...]
Kiadis Pharma to attend upcoming investor conferences in September 2018
28/08/2018
Kiadis Pharma to attend upcoming investor conferences in September 2018 Amsterdam, The Netherlands, August 28, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]
Orphazyme announces Interim Report First Half 2018
28/08/2018
Orphazyme A/S Company announcement No. 11/2018 Company Registration No. 32266355 The first part of 2018 has taken Orphazyme further along the path of bringing arimoclomol to rare disease patients in great need of new [...]
Wright Medical Group N.V. Announces Pricing of Public Offering of Ordinary Shares
28/08/2018
AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the pricing of its previously announced registered underwritten public offering of 18,248,932 of its [...]
EB Research Partnership and EB Research Foundation Join Forces to Advance Breakthroughs in Epidermolysis Bullosa Research
28/08/2018
The two leading global nonprofits announce a partnership to combine resources to heal EB NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- EB Research Partnership (EBRP), based in New York, and Australian-based EB Research [...]
Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema
27/08/2018
- In the pivotal study, patients taking TAKHZYRO 300 mg every 2 weeks had an 87% reduction in mean monthly attacks vs. placebo (0.26 vs. 1.97, n=27 vs. n=41) - All secondary endpoints were met and included reduction in [...]
Veritas Completes Share Purchase Agreement with 3 Carbon Extractions Inc.
27/08/2018
VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that the Company has completed the [...]
Akcea and Ionis Receive Complete Response Letter for WAYLIVRA from FDA
27/08/2018
CAMBRIDGE, Mass. and CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA) an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), today announced [...]
Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)
27/08/2018
– XERAVA™ Achieved High Clinical Cure Rates in Clinical Trials in Patients with cIAI – – Broad Product Label for Treatment of cIAI – – Commercial Launch Expected in the Fourth Quarter of 2018 – – Conference Call [...]
XBiotech annonce la publication de résultats décisifs sur le rôle potentiel de l'Interleukine-1 alpha dans le risque des crises cardiaques
27/08/2018
Les résultats montrent la capacité de MABp1 (Bermekimab) à bloquer l'activation endothéliale vasculaire par neutrophile in vitro et la thrombose AUSTIN, Texas, 27 août 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: [...]
Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets
27/08/2018
Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on sales Heidelberg, Germany, August 27, 2018 - Affimed N.V [...]
Alphatec to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
27/08/2018
CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]

Pages